SHANGHAI, China I February 25, 2025 I YolTech Therapeutics, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, today reported ...

Primary Hyperoxaluria (PH) is a rare autosomal recessive genetic disorder caused by enzyme deficiencies in hepatic oxalate metabolism, leading to excessive oxalate production and systemic oxalate ...

Tue, Feb 25, 2025, 3:15 AM 4 min read ...

Powerectus stands out as a leading contender for men seeking to enhance their performance, vitality, and overall health in dietary supplements. With a growing demand for male enhancement products ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator.